Comments
Loading...
Orientación y previsiones
Boston Scientific emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
07/23/2025 | BSX | Boston Scientific | FY | 2025 | $2.95 | $2.99 | $2.91 | $19.76B | $19.93B | $19.48B | |
07/23/2025 | BSX | Boston Scientific | Q3 | 2025 | $0.70 | $0.72 | $0.71 | $4.92B | $5.01B | $4.87B | |
05/28/2025 | BSX | Boston Scientific | FY | 2025 | $2.87 | $2.94 | $2.88 | $19.26B | $19.59B | $19.48B | |
05/28/2025 | BSX | Boston Scientific | Q2 | 2025 | $0.71 | $0.73 | $0.71 | $4.84B | $4.92B | $4.89B | |
04/23/2025 | BSX | Boston Scientific | Q2 | 2025 | $0.71 | $0.73 | $0.71 | $4.84B | $4.92B | $4.78B | |
04/23/2025 | BSX | Boston Scientific | FY | 2025 | $2.87 | $2.94 | $2.86 | $19.26B | $19.59B | $19.13B | |
02/05/2025 | BSX | Boston Scientific | Q1 | 2025 | $0.66 | $0.68 | $0.65 | $4.51B | $4.59B | $4.45B | |
02/05/2025 | BSX | Boston Scientific | FY | 2025 | $2.80 | $2.87 | $2.81 | $18.84B | $19.18B | $18.79B | |
10/23/2024 | BSX | Boston Scientific | Q4 | 2024 | $0.64 | $0.66 | $0.64 | $4.34B | $4.41B | $4.28B | |
10/23/2024 | BSX | Boston Scientific | FY | 2024 | $2.45 | $2.47 | $2.41 | $16.59B | $16.59B | $16.29B | |
07/24/2024 | BSX | Boston Scientific | Q3 | 2024 | $0.57 | $0.59 | $0.57 | $3.99B | $4.06B | $3.96B | |
07/24/2024 | BSX | Boston Scientific | FY | 2024 | $2.38 | $2.42 | $2.33 | $16.16B | $16.30B | $16.00B | |
04/24/2024 | BSX | Boston Scientific | FY | 2024 | $2.29 | $2.34 | $2.25 | $15.81B | $16.09B | $15.58B | |
04/24/2024 | BSX | Boston Scientific | Q2 | 2024 | $0.57 | $0.59 | $0.56 | $3.98B | $4.05B | $3.93B | |
01/31/2024 | BSX | Boston Scientific | FY | 2024 | $2.23 | $2.27 | $2.24 | $15.45B | $15.59B | $15.35B | |
01/31/2024 | BSX | Boston Scientific | Q1 | 2024 | $0.50 | $0.52 | $0.52 | $3.64B | $3.71B | $3.67B | |
10/26/2023 | BSX | Boston Scientific | FY | 2023 | $1.99 | $2.02 | $2.00 | $14.08B | $14.08B | $14.09B | |
10/26/2023 | BSX | Boston Scientific | Q4 | 2023 | $0.49 | $0.52 | $0.52 | $3.53B | $3.60B | $3.63B | |
09/20/2023 | BSX | Boston Scientific | FY | 2023 | $1.96 | $2.00 | $1.99 | $14.00B | $14.00B | $14.09B | |
07/27/2023 | BSX | Boston Scientific | FY | 2023 | $1.96 | $2.00 | $1.95 | $14.01B | $14.14B | $13.95B | |
07/27/2023 | BSX | Boston Scientific | Q3 | 2023 | $0.46 | $0.48 | $0.48 | $3.44B | $3.50B | $3.44B | |
04/26/2023 | BSX | Boston Scientific | FY | 2023 | $1.90 | $1.96 | $1.91 | $13.76B | $14.01B | $13.55B | |
04/26/2023 | BSX | Boston Scientific | Q2 | 2023 | $0.48 | $0.50 | $0.48 | $3.46B | $3.52B | $3.44B | |
02/01/2023 | BSX | Boston Scientific | FY | 2023 | $1.86 | $1.93 | $1.93 | $13.32B | $13.57B | $13.46B | |
02/01/2023 | BSX | Boston Scientific | Q1 | 2023 | $0.42 | $0.44 | $0.44 | $3.12B | $3.18B | $3.17B | |
10/26/2022 | BSX | Boston Scientific | FY | 2022 | $1.71 | $1.74 | $1.76 | $12.66B | $12.66B | $12.71B | |
10/26/2022 | BSX | Boston Scientific | Q4 | 2022 | $0.45 | $0.48 | $0.49 | $3.19B | $3.25B | $3.32B | |
07/27/2022 | BSX | Boston Scientific | FY | 2022 | $1.74 | $1.77 | $1.76 | $12.66B | $12.78B | $12.82B | |
07/27/2022 | BSX | Boston Scientific | Q3 | 2022 | $0.43 | $0.45 | $0.45 | $3.11B | $3.17B | $3.20B | |
04/27/2022 | BSX | Boston Scientific | FY | 2022 | $1.74 | $1.79 | $1.77 | $12.72B | $12.96B | $12.84B | |
04/27/2022 | BSX | Boston Scientific | Q2 | 2022 | $0.41 | $0.43 | $0.44 | $3.17B | $3.26B | $3.27B | |
02/02/2022 | BSX | Boston Scientific | FY | 2022 | $1.73 | $1.79 | $1.87 | $12.60B | $12.84B | $12.93B | |
02/02/2022 | BSX | Boston Scientific | Q1 | 2022 | $0.38 | $0.40 | $0.41 | $2.89B | $2.97B | $3.03B | |
10/27/2021 | BSX | Boston Scientific | Q4 | 2021 | $0.43 | $0.45 | $0.44 | $3.06B | $3.17B | $3.20B | |
10/27/2021 | BSX | Boston Scientific | FY | 2021 | $1.60 | $1.62 | $1.61 | $11.80B | $11.90B | $12.00B | |
09/22/2021 | BSX | Boston Scientific | FY | 2021 | $1.58 | $1.62 | $1.61 | $12.00B | $12.00B | $12.01B | |
07/27/2021 | BSX | Boston Scientific | Q3 | 2021 | $0.39 | $0.41 | $0.40 | $2.98B | $3.03B | $2.97B | |
07/27/2021 | BSX | Boston Scientific | FY | 2021 | $1.58 | $1.62 | $1.58 | $11.99B | $12.09B | $11.75B | |
04/28/2021 | BSX | Boston Scientific | Q2 | 2021 | $0.36 | $0.38 | $0.35 | $2.92B | $3.00B | $2.76B | |
04/28/2021 | BSX | Boston Scientific | FY | 2021 | $1.53 | $1.60 | $1.54 | $11.50B | $11.80B | $11.43B | |
02/03/2021 | BSX | Boston Scientific | Q1 | 2021 | $0.28 | $0.34 | $0.35 | $2.54B | $2.70B | $2.73B | |
02/03/2021 | BSX | Boston Scientific | FY | 2021 | $1.50 | $1.60 | $1.62 | $11.20B | $11.80B | $11.53B | |
01/12/2021 | BSX | Boston Scientific | FY | 2020 | — | — | — | $9.91B | $9.91B | $10.08B | |
01/12/2021 | BSX | Boston Scientific | Q4 | 2020 | — | — | — | $2.71B | $2.71B | $2.86B |
PREGUNTAS FRECUENTES
¿Cuál es la orientación más reciente de Boston Scientific (BSX)?
La orientación más reciente para Boston Scientific (BSX) se informó el julio 23, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $2.95 a $2.99, en comparación con el EPS estimado de $2.91. Además, Boston Scientific pronosticó ingresos entre $19.76B y $19.93B para el trimestre.
Explora orientación y previsión sobre todos los valores.